(Q46666595)

24 December 2017

title

Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects (English)

1 reference

24 December 2017

1 reference

1 reference

Kyoung-Ah Kim

1

1 reference

24 December 2017

Pil-Whan Park

series ordinal

2

1 reference

24 December 2017

Ji-Young Park

series ordinal

3

1 reference

24 December 2017

publication date

1 June 2008

1 reference

24 December 2017

European Journal of Clinical Pharmacology

published in

1 reference

24 December 2017

volume

64

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

589-597

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s00228-008-0471-0

exact match

0 references

cites work

Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00228-008-0471-0

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genes.

21 January 2018

1 reference

12 December 2020

The genetic determinants of the CYP3A5 polymorphism

1 reference

12 December 2020

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles

1 reference

12 December 2020

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

1 reference

12 December 2020

Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism

1 reference

12 December 2020

Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction

1 reference

12 December 2020

Novel detection assay by PCR-RFLP and frequency of the CYP3A5 SNPs, CYP3A5*3 and *6, in a Japanese population

1 reference

12 December 2020

An interethnic comparison of polymorphisms of the genes encoding drug-metabolizing enzymes and drug transporters: experience in Singapore

1 reference

12 December 2020

The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin

1 reference

12 December 2020

Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of [...]

1 reference

12 December 2020

P2y(12), a new platelet ADP receptor, target of clopidogrel

1 reference

12 December 2020

Structure and stereochemistry of the active metabolite of clopidogrel

1 reference

12 December 2020

Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested

1 reference

12 December 2020

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement

1 reference

12 December 2020

Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.

1 reference

12 December 2020

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel

1 reference

12 December 2020

Identification and biological activity of the active metabolite of clopidogrel

1 reference

12 December 2020

CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity

1 reference

12 December 2020

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

1 reference

12 December 2020

CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer

1 reference

12 December 2020

Pharmacokinetics of clopidogrel

1 reference

12 December 2020

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

12 December 2020

Effect of polymorphic CYP3A5 genotype on the single-dose simvastatin pharmacokinetics in healthy subjects.

1 reference

12 December 2020

Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients

1 reference

12 December 2020

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

1 reference

12 December 2020

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers

1 reference

12 December 2020

Resistance to clopidogrel: a review of the evidence

1 reference

12 December 2020

Impact of P-glycoprotein on clopidogrel absorption

1 reference

12 December 2020

CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels

1 reference

12 December 2020

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

1 reference

12 December 2020

807 C/T Polymorphism of the glycoprotein Ia gene and pharmacogenetic modulation of platelet response to dual antiplatelet treatment

1 reference

12 December 2020

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

12 December 2020

Durability of platelet inhibition by clopidogrel

1 reference

12 December 2020

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

1 reference

12 December 2020

Effects of the CYP3A5 genetic polymorphism on the pharmacokinetics of diltiazem

1 reference

12 December 2020

Aspirin and clopidogrel resistance

1 reference

12 December 2020

Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7.

1 reference

12 December 2020

Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of alprazolam in healthy subjects.

1 reference

12 December 2020

Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently

1 reference

12 December 2020

Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance

1 reference

12 December 2020

Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.

1 reference

12 December 2020

Genotype relationships in the CYP3A locus in Caucasians.

1 reference

12 December 2020

ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin.

1 reference

12 December 2020

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

12 December 2020

Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects.

1 reference

12 December 2020

Biochemical and pharmacological activities of SR 26831, a potent and selective elastase inhibitor

1 reference

12 December 2020

10.1007/S00228-008-0471-0

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18385991

1 reference

24 December 2017